Last reviewed · How we verify
Malignant tumor of peritoneum
Approved treatments
- Avastin · Washington University School of Medicine
- Zejula · GSK
Zejula works by blocking the action of an enzyme called PARP, which helps repair damaged DNA in cancer cells. - Bevacizumab · Roche
Bevacizumab binds VEGF and prevents interaction with endothelial cell receptors Flt-1 and KDR. - Taxol · Pfizer
Taxol works by binding to tubulin and preventing the formation of microtubules, which are essential for cell division. - Lynparza · University of Texas Southwestern Medical Center
- Lynparza · AstraZeneca
Lynparza blocks the repair of DNA damage in cancer cells by inhibiting the enzyme PARP. - Taxol · Pfizer
- Avastin · Roche
Bevacizumab works by binding to VEGF-A, preventing it from promoting the growth of new blood vessels that feed tumors. - Taxol · Pfizer
- Abraxane · The First Affiliated Hospital with Nanjing Medical University
- Taxol · M.D. Anderson Cancer Center
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Malignant tumor of peritoneum patent landscape — cliff calendar, originator estates, attackable patents
- Malignant tumor of peritoneum treatment landscape brief
- Malignant tumor of peritoneum treatment updates RSS
Frequently asked questions about Malignant tumor of peritoneum
What drugs treat Malignant tumor of peritoneum?
Tracked treatments include Avastin, Zejula, Bevacizumab, Taxol, Lynparza, Abraxane.
What is the treatment for Malignant tumor of peritoneum?
Standard treatment for Malignant tumor of peritoneum includes Avastin, Zejula, Bevacizumab, Taxol, Lynparza. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Malignant tumor of peritoneum patent cliff · Malignant tumor of peritoneum CI report
- Treatment: Avastin · Washington University School of Medicine
- Treatment: Zejula · GSK
- Treatment: Bevacizumab · Roche
- Treatment: Taxol · Pfizer
- Treatment: Lynparza · University of Texas Southwestern Medical Center
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing